Argatroban 1 mg (Argatroban SOLUTION) 1 MG

Argatroban 1 mg is an intravenous solution used for anticoagulation. This medication is often prescribed to prevent blood clots in specific medical conditions.

Strength

1 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Argatroban is primarily used for anticoagulation, helping to prevent the formation of blood clots. It is often administered to patients who are at risk of clotting disorders or those undergoing certain medical procedures. The solution is designed for intravenous use, ensuring quick and effective action.

Side Effects

Common effects of Argatroban may include changes in blood clotting times. Patients should monitor for any unusual bleeding or bruising and report these symptoms to their healthcare provider. The medication works by inhibiting certain enzymes involved in the clotting process.

Precautions & Warnings

Argatroban should be handled with care, as it is intended for use under medical supervision. Patients with a history of bleeding disorders or those taking other blood-thinning medications should use this solution cautiously. Always follow the guidance of a healthcare professional when administering Argatroban.

Avoid Interactions

Argatroban may interact with other medications that affect blood clotting, including certain anticoagulants and antiplatelet drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect blood clotting should also be considered.

Frequently Asked Questions

Argatroban is used for anticoagulation to prevent blood clots in certain medical conditions.

Argatroban is administered intravenously, typically under medical supervision.

Common effects may include changes in blood clotting times and increased risk of bleeding.

Patients with a history of bleeding disorders or those taking other blood-thinning medications should use Argatroban cautiously.

Yes, Argatroban may interact with other anticoagulants and antiplatelet drugs, so it's important to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.